216 related articles for article (PubMed ID: 19528485)
41. Differential expression of EphA7 receptor tyrosine kinase in gastric carcinoma.
Wang J; Li G; Ma H; Bao Y; Wang X; Zhou H; Sheng Z; Sugimura H; Jin J; Zhou X
Hum Pathol; 2007 Nov; 38(11):1649-56. PubMed ID: 17669470
[TBL] [Abstract][Full Text] [Related]
42. DNA methylation profile in diffuse type gastric cancer: evidence for hypermethylation of the BRCA1 promoter region in early-onset gastric carcinogenesis.
Bernal C; Vargas M; Ossandón F; Santibáñez E; Urrutia J; Luengo V; Zavala LF; Backhouse C; Palma M; Argandoña J; Aguayo F; Corvalán A
Biol Res; 2008; 41(3):303-15. PubMed ID: 19399343
[TBL] [Abstract][Full Text] [Related]
43. Effect of promoter methylation of multidrug resistance 1 (MDR1) gene in gastric carcinogenesis.
Tahara T; Arisawa T; Shibata T; Yamashita H; Yoshioka D; Hirata I
Anticancer Res; 2009 Jan; 29(1):337-41. PubMed ID: 19331170
[TBL] [Abstract][Full Text] [Related]
44. Methylation patterns of Rb1 and Casp-8 promoters and their impact on their expression in bladder cancer.
Malekzadeh K; Sobti RC; Nikbakht M; Shekari M; Hosseini SA; Tamandani DK; Singh SK
Cancer Invest; 2009 Jan; 27(1):70-80. PubMed ID: 19160091
[TBL] [Abstract][Full Text] [Related]
45. Methylation of the claudin‑3 promoter predicts the prognosis of advanced gastric adenocarcinoma.
Zhang Z; Yu W; Chen S; Chen Y; Chen L; Zhang S
Oncol Rep; 2018 Jul; 40(1):49-60. PubMed ID: 29749528
[TBL] [Abstract][Full Text] [Related]
46. Biological significance of promoter hypermethylation of tumor-related genes in patients with gastric carcinoma.
Ksiaa F; Ziadi S; Amara K; Korbi S; Trimeche M
Clin Chim Acta; 2009 Jun; 404(2):128-33. PubMed ID: 19336228
[TBL] [Abstract][Full Text] [Related]
47. Methylation of OSMR gene is frequently observed in non-invasive colorectal cancer.
Hibi K; Goto T; Sakuraba K; Shirahata A; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
Anticancer Res; 2011 Apr; 31(4):1293-5. PubMed ID: 21508378
[TBL] [Abstract][Full Text] [Related]
48. Aberrant silencing of the endocrine peptide gene tachykinin-1 in gastric cancer.
David S; Kan T; Cheng Y; Agarwal R; Jin Z; Mori Y
Biochem Biophys Res Commun; 2009 Jan; 378(3):605-9. PubMed ID: 19046942
[TBL] [Abstract][Full Text] [Related]
49. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
50. Promoter methylation profile in preneoplastic and neoplastic gallbladder lesions.
García P; Manterola C; Araya JC; Villaseca M; Guzmán P; Sanhueza A; Thomas M; Alvarez H; Roa JC
Mol Carcinog; 2009 Jan; 48(1):79-89. PubMed ID: 18543280
[TBL] [Abstract][Full Text] [Related]
51. Adenomatous polyposis coli 1A is likely to be methylated as a passenger in human gastric carcinogenesis.
Hosoya K; Yamashita S; Ando T; Nakajima T; Itoh F; Ushijima T
Cancer Lett; 2009 Nov; 285(2):182-9. PubMed ID: 19527921
[TBL] [Abstract][Full Text] [Related]
52. Clinicopathological and molecular characteristics of gastric and colorectal carcinomas in the elderly.
Arai T; Takubo K
Pathol Int; 2007 Jun; 57(6):303-14. PubMed ID: 17539960
[TBL] [Abstract][Full Text] [Related]
53. Impact of catechol-O-methyltransferase (COMT) gene polymorphism on promoter methylation status in gastric mucosa.
Tahara T; Shibata T; Arisawa T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nagasaka M; Iwata M; Takahama K; Watanabe M; Hirata I
Anticancer Res; 2009 Jul; 29(7):2857-61. PubMed ID: 19596974
[TBL] [Abstract][Full Text] [Related]
54. Methylation-mediated repression of GADD45A and GADD45G expression in gastric cardia adenocarcinoma.
Guo W; Dong Z; Guo Y; Chen Z; Kuang G; Yang Z
Int J Cancer; 2013 Nov; 133(9):2043-53. PubMed ID: 23616123
[TBL] [Abstract][Full Text] [Related]
55. Immunohistochemical staining for P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha may complement mucin phenotype of differentiated-type early gastric carcinoma.
Takano K; Hasegawa G; Jiang S; Kurosaki I; Hatakeyama K; Iwanari H; Tanaka T; Hamakubo T; Kodama T; Naito M
Pathol Int; 2009 Jul; 59(7):462-70. PubMed ID: 19563409
[TBL] [Abstract][Full Text] [Related]
56. Genetic alterations of the ATBF1 gene in gastric cancer.
Cho YG; Song JH; Kim CJ; Lee YS; Kim SY; Nam SW; Lee JY; Park WS
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4355-9. PubMed ID: 17671116
[TBL] [Abstract][Full Text] [Related]
57. Reprimo as a potential biomarker for early detection in gastric cancer.
Bernal C; Aguayo F; Villarroel C; Vargas M; Díaz I; Ossandon FJ; Santibáñez E; Palma M; Aravena E; Barrientos C; Corvalan AH
Clin Cancer Res; 2008 Oct; 14(19):6264-9. PubMed ID: 18829507
[TBL] [Abstract][Full Text] [Related]
58. Expression of multidrug resistance-related proteins p-glycoprotein, glutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Hepatogastroenterology; 2008; 55(86-87):1530-6. PubMed ID: 19102336
[TBL] [Abstract][Full Text] [Related]
59. Expression of ERas oncogene in gastric carcinoma.
Kaizaki R; Yashiro M; Shinto O; Yasuda K; Matsuzaki T; Sawada T; Hirakawa K
Anticancer Res; 2009 Jun; 29(6):2189-93. PubMed ID: 19528480
[TBL] [Abstract][Full Text] [Related]
60. Aristaless-like homeobox-4 gene methylation is a potential marker for colorectal adenocarcinomas.
Ebert MP; Model F; Mooney S; Hale K; Lograsso J; Tonnes-Priddy L; Hoffmann J; Csepregi A; Röcken C; Molnar B; Schulz HU; Malfertheiner P; Lofton-Day C
Gastroenterology; 2006 Nov; 131(5):1418-30. PubMed ID: 17101318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
